BLCONYSESEC EDGAREDGAR

Bausch & Lomb Corp

Ophthalmic Goods·VAUGHAN, A6·FY end 12/31·CIK 1860742

Board of Directors

9 members · 8 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Eduardo Alfonso, M.D.Director0y73
Nathalie BernierDirector4y62AuditTech$781,308
Steven H. CollisDirector0y64
Sarah B. KavanaghDirector4y69AuditNCG$528,439
Karen L. LingDirector2y62Comp$337,994
John A. PaulsonDirector4y70NCG$827,925
Russel C. RobertsonDirector4y78AuditComp$824,773
Thomas W. Ross, Sr.Lead Independent4y75NCGComp$705,720
Brenton L. SaundersChair3y56

Risk-factor diff

FY 2025 10-K vs. FY 2024
+307 new326 removed

Net-new paragraphs in the most recent 10-K's Item 1A. Companies rarely add risk language without a real reason — additions here are often a leading signal of management concerns.

NEW · FY 2025

—We expect to make payments of approximately $285 million for property, plant and equipment in 2026;

NEW · FY 2025

—We expect to make aggregate payments under our pension and postretirement obligations of $8 million in 2026. See Note 11, “PENSION AND POSTRETIREMENT EMPLOYEE BENEFIT PLANS” to our audited Consolidated Financial Statements for the year ended December 31, 2025, for additional information on pension and postretirement obligations included in this Form 10-K and;

NEW · FY 2025

— Under the terms of a December 2019 license agreement with Novaliq GmbH, the Company is required to make future sales-based payments for MIEBO

NEW · FY 2025

, and, as a result of achieving a sales-based milestone, the Company accrued a $35 million milestone payment as of September 30, 2025, which is anticipated to be paid during the first quarter of 2026.

NEW · FY 2025

At February 11, 2026, we had 354,318,198 issued and outstanding common shares. In addition, as of February 11, 2026, we had outstanding approximately 10,000,000 stock options and 6,900,000 restricted share units that each represent the right of a holder to receive one of Bausch + Lomb’s common shares and 5,100,000 performance-based restricted share units that represent the right of a holder to receive a number of the Company’s common shares up to a specified maximum. A maximum of approximately 11,900,000 common shares could be issued upon vesting of the performance-based restricted share units…

+ 25 more new paragraphs not shown

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.